Form 8-K - Current report:
SEC Accession No. 0000950170-24-072249
Filing Date
2024-06-12
Accepted
2024-06-12 06:55:32
Documents
112
Period of Report
2024-06-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prld-20240612.htm   iXBRL 8-K 50970
2 EX-99.1 prld-ex99_1.htm EX-99.1 28146
3 EX-99.2 prld-ex99_2.htm EX-99.2 51964
4 GRAPHIC prld-ex99_1s1.jpg GRAPHIC 491563
5 GRAPHIC prld-ex99_1s2.jpg GRAPHIC 819410
6 GRAPHIC prld-ex99_1s3.jpg GRAPHIC 383242
7 GRAPHIC prld-ex99_1s4.jpg GRAPHIC 470436
8 GRAPHIC prld-ex99_1s5.jpg GRAPHIC 399796
9 GRAPHIC prld-ex99_1s6.jpg GRAPHIC 532599
10 GRAPHIC prld-ex99_1s7.jpg GRAPHIC 393413
11 GRAPHIC prld-ex99_1s8.jpg GRAPHIC 495660
12 GRAPHIC prld-ex99_1s9.jpg GRAPHIC 388265
13 GRAPHIC prld-ex99_1s10.jpg GRAPHIC 483343
14 GRAPHIC prld-ex99_1s11.jpg GRAPHIC 496340
15 GRAPHIC prld-ex99_1s12.jpg GRAPHIC 488844
16 GRAPHIC prld-ex99_1s13.jpg GRAPHIC 432650
17 GRAPHIC prld-ex99_1s14.jpg GRAPHIC 358557
18 GRAPHIC prld-ex99_1s15.jpg GRAPHIC 458323
19 GRAPHIC prld-ex99_1s16.jpg GRAPHIC 463137
20 GRAPHIC prld-ex99_1s17.jpg GRAPHIC 331324
21 GRAPHIC prld-ex99_1s18.jpg GRAPHIC 365262
22 GRAPHIC prld-ex99_1s19.jpg GRAPHIC 416112
23 GRAPHIC prld-ex99_1s20.jpg GRAPHIC 485386
24 GRAPHIC prld-ex99_1s21.jpg GRAPHIC 325788
25 GRAPHIC prld-ex99_1s22.jpg GRAPHIC 355611
26 GRAPHIC prld-ex99_1s23.jpg GRAPHIC 413373
27 GRAPHIC prld-ex99_1s24.jpg GRAPHIC 449278
28 GRAPHIC prld-ex99_1s25.jpg GRAPHIC 401552
29 GRAPHIC prld-ex99_1s26.jpg GRAPHIC 500050
30 GRAPHIC prld-ex99_1s27.jpg GRAPHIC 466237
31 GRAPHIC prld-ex99_1s28.jpg GRAPHIC 416218
32 GRAPHIC prld-ex99_1s29.jpg GRAPHIC 327321
33 GRAPHIC prld-ex99_2s1.jpg GRAPHIC 330412
34 GRAPHIC prld-ex99_2s2.jpg GRAPHIC 831321
35 GRAPHIC prld-ex99_2s3.jpg GRAPHIC 347470
36 GRAPHIC prld-ex99_2s4.jpg GRAPHIC 309304
37 GRAPHIC prld-ex99_2s5.jpg GRAPHIC 346243
38 GRAPHIC prld-ex99_2s6.jpg GRAPHIC 358675
39 GRAPHIC prld-ex99_2s7.jpg GRAPHIC 341274
40 GRAPHIC prld-ex99_2s8.jpg GRAPHIC 461894
41 GRAPHIC prld-ex99_2s9.jpg GRAPHIC 349671
42 GRAPHIC prld-ex99_2s10.jpg GRAPHIC 261321
43 GRAPHIC prld-ex99_2s11.jpg GRAPHIC 357169
44 GRAPHIC prld-ex99_2s12.jpg GRAPHIC 363749
45 GRAPHIC prld-ex99_2s13.jpg GRAPHIC 454446
46 GRAPHIC prld-ex99_2s14.jpg GRAPHIC 324507
47 GRAPHIC prld-ex99_2s15.jpg GRAPHIC 363380
48 GRAPHIC prld-ex99_2s16.jpg GRAPHIC 444913
49 GRAPHIC prld-ex99_2s17.jpg GRAPHIC 378110
50 GRAPHIC prld-ex99_2s18.jpg GRAPHIC 389871
51 GRAPHIC prld-ex99_2s19.jpg GRAPHIC 356223
52 GRAPHIC prld-ex99_2s20.jpg GRAPHIC 358310
53 GRAPHIC prld-ex99_2s21.jpg GRAPHIC 394722
54 GRAPHIC prld-ex99_2s22.jpg GRAPHIC 204313
55 GRAPHIC prld-ex99_2s23.jpg GRAPHIC 445396
56 GRAPHIC prld-ex99_2s24.jpg GRAPHIC 342277
57 GRAPHIC prld-ex99_2s25.jpg GRAPHIC 404287
58 GRAPHIC prld-ex99_2s26.jpg GRAPHIC 380100
59 GRAPHIC prld-ex99_2s27.jpg GRAPHIC 324613
60 GRAPHIC prld-ex99_2s28.jpg GRAPHIC 503679
61 GRAPHIC prld-ex99_2s29.jpg GRAPHIC 387750
62 GRAPHIC prld-ex99_2s30.jpg GRAPHIC 445168
63 GRAPHIC prld-ex99_2s31.jpg GRAPHIC 428762
64 GRAPHIC prld-ex99_2s32.jpg GRAPHIC 420816
65 GRAPHIC prld-ex99_2s33.jpg GRAPHIC 348404
66 GRAPHIC prld-ex99_2s34.jpg GRAPHIC 349567
67 GRAPHIC prld-ex99_2s35.jpg GRAPHIC 392725
68 GRAPHIC prld-ex99_2s36.jpg GRAPHIC 213594
69 GRAPHIC prld-ex99_2s37.jpg GRAPHIC 389872
70 GRAPHIC prld-ex99_2s38.jpg GRAPHIC 443531
71 GRAPHIC prld-ex99_2s39.jpg GRAPHIC 418389
72 GRAPHIC prld-ex99_2s40.jpg GRAPHIC 428413
73 GRAPHIC prld-ex99_2s41.jpg GRAPHIC 331184
74 GRAPHIC prld-ex99_2s42.jpg GRAPHIC 285478
75 GRAPHIC prld-ex99_2s43.jpg GRAPHIC 289823
76 GRAPHIC prld-ex99_2s44.jpg GRAPHIC 362369
77 GRAPHIC prld-ex99_2s45.jpg GRAPHIC 233642
78 GRAPHIC prld-ex99_2s46.jpg GRAPHIC 296527
79 GRAPHIC prld-ex99_2s47.jpg GRAPHIC 349937
80 GRAPHIC prld-ex99_2s48.jpg GRAPHIC 336917
81 GRAPHIC prld-ex99_2s49.jpg GRAPHIC 314469
82 GRAPHIC prld-ex99_2s50.jpg GRAPHIC 356111
83 GRAPHIC prld-ex99_2s51.jpg GRAPHIC 303208
84 GRAPHIC prld-ex99_2s52.jpg GRAPHIC 354226
85 GRAPHIC prld-ex99_2s53.jpg GRAPHIC 339849
86 GRAPHIC prld-ex99_2s54.jpg GRAPHIC 373142
87 GRAPHIC prld-ex99_2s55.jpg GRAPHIC 293571
88 GRAPHIC prld-ex99_2s56.jpg GRAPHIC 376432
89 GRAPHIC prld-ex99_2s57.jpg GRAPHIC 563256
90 GRAPHIC prld-ex99_2s58.jpg GRAPHIC 357740
91 GRAPHIC prld-ex99_2s59.jpg GRAPHIC 276844
92 GRAPHIC prld-ex99_2s60.jpg GRAPHIC 413095
93 GRAPHIC prld-ex99_2s61.jpg GRAPHIC 438899
94 GRAPHIC prld-ex99_2s62.jpg GRAPHIC 341284
95 GRAPHIC prld-ex99_2s63.jpg GRAPHIC 361206
96 GRAPHIC prld-ex99_2s64.jpg GRAPHIC 225878
97 GRAPHIC prld-ex99_2s65.jpg GRAPHIC 379625
98 GRAPHIC prld-ex99_2s66.jpg GRAPHIC 333783
99 GRAPHIC prld-ex99_2s67.jpg GRAPHIC 418383
100 GRAPHIC prld-ex99_2s68.jpg GRAPHIC 482561
101 GRAPHIC prld-ex99_2s69.jpg GRAPHIC 414936
102 GRAPHIC prld-ex99_2s70.jpg GRAPHIC 309507
  Complete submission text file 0000950170-24-072249.txt   53623968

Data Files

Seq Description Document Type Size
103 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20240612.xsd EX-101.SCH 50436
115 EXTRACTED XBRL INSTANCE DOCUMENT prld-20240612_htm.xml XML 4721
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

EIN.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39527 | Film No.: 241037476
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)